Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. (TEMPO)

This study has been completed.
Sponsor:
Collaborators:
Aarhus University Hospital
Bispebjerg Hospital
Actelion
Information provided by (Responsible Party):
Anders Hebert, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01292551
First received: February 8, 2011
Last updated: April 18, 2013
Last verified: April 2013